Public Health Innovation Lab (PHiL) works to close the technology gap in global public health by coordinating technologists, data scientists, policymakers, and community partners. It develops and scales digital tools that improve health data collection, analysis, and sharing, while reducing inefficiencies in outreach and service delivery. By fostering sustained public‑private collaboration, PHiL aims to deliver cost‑effective solutions that enhance safety and outcomes for medicines, vaccines, and essential health services.
Funding
Funding not disclosed
Founders
Product
Problem
Public health institutions and health systems worldwide rely on outdated data collection and analysis tools, leading to inaccurate health data, inefficient outreach, and unsafe vaccine and medicine monitoring. This technology gap contributes to preventable child mortality and hampers effective disease surveillance.
Solution
PHiL offers a digital platform that modernizes the entire public‑health data lifecycle—from real‑time data capture to advanced analytics and secure sharing. By integrating existing technologies with custom adaptations, the platform reduces manual errors, streamlines service delivery, and enables rapid, evidence‑based interventions. Collaborative networks of technologists, data scientists, public‑health experts, and policymakers ensure the tools stay aligned with evolving health priorities. The system supports cost‑effective solutions for vaccine and medicine safety monitoring and can be deployed across diverse health infrastructures, from low‑resource clinics to national health agencies.
Target Audience
Primary users are national and regional public‑health agencies, ministries of health, and large health‑system networks that need reliable, scalable data solutions for disease monitoring and service delivery.
Features
- Cloud‑based data collection modules that standardize and automate field reporting, minimizing transcription errors
- Real‑time analytics dashboards with visualizations for disease surveillance, outbreak detection, and resource allocation
- Secure data sharing APIs that enable interoperability with existing health information systems and facilitate cross‑sector collaboration
- Built‑in safety monitoring tools for vaccines and medicines, including adverse event tracking and automated alert generation
- Modular architecture allowing integration of emerging technologies (e.g., mobile sensors, AI models) without extensive redevelopment
- Community‑driven governance framework that brings together researchers, policymakers, and local health workers to guide platform evolution